Oxbow Advisors, LLC Novartis Ag Transaction History
Oxbow Advisors, LLC
- $883 Million
- Q3 2025
A detailed history of Oxbow Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Oxbow Advisors, LLC holds 28,840 shares of NVS stock, worth $3.79 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
28,840
Previous 28,619
0.77%
Holding current value
$3.79 Million
Previous $3.46 Million
6.79%
% of portfolio
0.42%
Previous 0.45%
Shares
14 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...